FDA Advisory Panel Votes 7 To 5 To Recommend Approval Of Atritech, Inc.'s Watchman LAA Closure Device

Published: Apr 24, 2009

Bookmark and Share

The Heart -- A US Food and Drug Administration advisory panel voted 7 to 5 in favor of approving a device for closure of the left atrial appendage (LAA) as an alternative to long-term warfarin therapy for the prevention of stroke in warfarin-eligible patients with nonvalvular atrial fibrillation (AF).

Back to news